Why Sensitivity to Unobserved Outcomes Matters
When participants leave follow-up, their later biomarker values are not recorded. The mean among participants who remain can still be calculated, but it need not describe the trajectory of the original cohort. As the earlier material on observed follow-up and dropout emphasizes, the people still observed may differ from those no longer contributing measurements. The size and direction of that difference cannot generally be learned from the observed later measurements alone.
A sensitivity analysis makes this uncertainty explicit. Instead of treating one unverifiable assumption about missing outcomes as known, it asks how conclusions would change under a range of plausible hypothetical values. The purpose is not to reconstruct each person's actual unobserved value. It is to show how much a cohort-level summary depends on assumptions about the outcomes that dropout concealed.
This distinction requires care. The examples below concern nonterminal dropout while the biomarker remains conceptually defined. After a terminal event such as death, a later biomarker may not be a missing value at all: it may be undefined. Treating such an outcome as if it could simply be imputed would change the scientific question.
A Simple Pattern-Mixture Sensitivity Model
Fix a follow-up time \(t\). Let \(q(t)\) be the proportion of the original cohort whose biomarker is unobserved at that time, and let \(m_{\mathrm{obs}}(t)\) be the mean among those observed. Let \(m_{\mathrm{mis,MAR}}(t)\) be a benchmark mean for those missing, predicted from their observed information under a missing-at-random (MAR) assumption. In this setting, MAR means that, conditional on the observed information used in the model, the probability of a missing outcome does not depend on its unobserved value.
The benchmark is an assumption, not something established by the observed data. A pattern-mixture sensitivity analysis shifts the benchmark missing-outcome mean by a chosen amount \(\delta(t)\), measured in the biomarker's units:
A negative \(\delta(t)\) represents a missing group whose average is lower than the benchmark; a positive value represents a higher average. It is a shift in the group mean, not a claim that every missing participant has exactly the same individual-level change. Combining observed and missing groups gives the sensitivity-adjusted cohort mean:
For a fixed benchmark, changing \(\delta(t)\) by one biomarker unit changes the cohort mean by \(q(t)\) units. Thus the same departure matters more when a larger fraction of the cohort is missing. In practice, the benchmark may come from a model using observed histories, and the missing fraction and group means may be estimated. The arithmetic below treats them as known to keep attention on the sensitivity calculation; it does not represent sampling uncertainty.
Worked Example: A Lower Mean After Dropout
Suppose a hypothetical cohort began with 100 participants. At 12 months, 70 have a recorded biomarker value with mean 8.0 units, and 30 have dropped out. A model-based MAR benchmark predicts a mean of 7.5 units for those 30 participants. Consider the sensitivity assumption that their actual group mean would be 2.0 units lower than that benchmark.
Here \(q=30/100=0.30\), \(m_{\mathrm{obs}}=8.0\), \(m_{\mathrm{mis,MAR}}=7.5\), and \(\delta=-2.0\) units. The assumed missing-group mean is:
The cohort mean under this assumption is:
Under the MAR benchmark, the corresponding mean would be \(0.70(8.0)+0.30(7.5)=5.60+2.25=7.85\) units. The assumed two-unit shift for the missing group therefore lowers the cohort mean by \(7.85-7.25=0.60\) units, which also equals \(q\lvert\delta\rvert=0.30(2.0)\). These calculations show the consequences of the assumption; they do not establish that the missing participants' mean was 5.5 units.
From a Single-Time Mean to a Trajectory
A cohort trajectory is a sequence of cohort means across time. Sensitivity assumptions can be specified separately at each time, or summarized by a pattern such as a constant shift over follow-up. A constant \(\delta\) is convenient for illustration, but it is not automatically plausible: the gap between missing and benchmark outcomes could grow, shrink, or change direction over time. Any trajectory comparison must apply assumptions consistently at the times being compared.
For a two-time-point illustration, suppose the baseline biomarker is observed for the full cohort. The change in the cohort mean is the adjusted follow-up mean minus the baseline mean. This change describes a difference in population averages over time; it does not imply that every participant changed by that amount.
Worked Example: When a Decline Crosses a Practical Threshold
In a hypothetical cohort of 100 participants, the baseline mean is 10.0 units. At 12 months, 80 participants are observed, and their mean is 8.0 units. For the 20 who dropped out, the MAR benchmark mean is 7.5 units. Investigators want to know whether the cohort's mean decline is greater than 2.4 units. Examine how far below the benchmark the missing group would need to be for that conclusion to hold.
The missing fraction is \(q=0.20\), so under a shift \(\delta\), the adjusted 12-month mean is:
The change from baseline is therefore \((7.9+0.20\delta)-10.0=-2.1+0.20\delta\) units. A decline greater than 2.4 units means this change is less than \(-2.4\). Solving the inequality gives:
Thus the missing group's mean must be more than 1.5 units below its MAR benchmark for the estimated decline to exceed 2.4 units. At \(\delta=-2.0\), the adjusted follow-up mean is \(7.9+0.20(-2.0)=7.5\) units, giving a decline of \(10.0-7.5=2.5\) units. At the MAR benchmark, \(\delta=0\), the decline is only \(10.0-7.9=2.1\) units. The threshold calculation identifies a tipping point for this chosen criterion; it does not tell us which missing-outcome scenario is true.
Making the Assumptions and Checks Explicit
Before interpreting a sensitivity calculation, verify that its target and inputs are coherent. The biomarker must be defined for the people and times included in the cohort mean; dropout status and the denominator must be clear; the observed measurements must be comparable across participants; and the benchmark for missing outcomes must be described. If that benchmark uses a prediction model, its conditional assumptions and included history matter. A shift \(\delta\) changes the assumption about missing outcomes; it does not fix a poorly chosen benchmark.
Name the time point or trajectory summary and define whose biomarker values it is intended to represent. Separate nonterminal dropout from outcomes made undefined by a terminal event.
State how the missing-group mean is predicted under MAR, including what observed history informs the prediction. Treat this as a reference scenario, not a verified fact.
Choose a range of \(\delta(t)\) values that can be interpreted in biomarker units and assessed for plausibility. Calculate the target summary for each scenario.
Show which conclusions persist across the scenarios and where they change. When making statistical inferences, account for sampling uncertainty as well as the sensitivity assumptions.
Useful checks include confirming that the missing fraction and group weights sum to one, checking that assumed means remain within scientifically possible values, and plotting adjusted means across the chosen \(\delta\) range. If biomarker values are bounded, a scenario that implies a group mean outside those bounds is not plausible. If dropout proportions or dropout patterns change sharply over time, a single constant shift may conceal important variation. These checks can expose an incoherent scenario, but they cannot reveal the unobserved outcomes.
Worked Example: Finding the Tipping Point for a Mean Threshold
Suppose, hypothetically, 60% of a cohort is observed at follow-up, with mean 7.6 units. The missing 40% have a MAR benchmark mean of 7.2 units. The question is whether the full-cohort mean is above 7.0 units. Write the adjusted mean as a function of the shift:
The mean is above 7.0 when \(7.44+0.40\delta>7.0\), or \(0.40\delta>-0.44\), so \(\delta>-1.1\) units. At \(\delta=-1.1\), the mean is exactly 7.0 units; at \(\delta=-1.5\), it is \(7.44-0.60=6.84\) units. Therefore, the conclusion that the cohort mean exceeds 7.0 is sensitive to assumptions in which the missing group's mean is more than 1.1 units below its benchmark. The calculation locates the boundary of the conclusion, rather than estimating the most likely shift.
What Sensitivity Analysis Can and Cannot Establish
Sensitivity analysis is most informative when the assumptions are stated in recognizable units and the range is justified using subject-matter knowledge, earlier measurements, or scientifically meaningful limits. Reporting only the MAR result can make an unverifiable assumption look like a data-driven certainty. Reporting a range shows whether a conclusion is robust to departures from that assumption.
The method has important limits. Observed data alone generally cannot identify the mean of outcomes that remain unobserved under nonrandom dropout. A selected set of \(\delta\) values does not turn those unknown outcomes into known data, and a conclusion that persists over a narrow or implausible range is not evidence of robustness over all possible departures. Sensitivity scenarios also do not remove ordinary sampling error. In a full analysis, uncertainty in estimated observed means, dropout proportions, benchmark predictions, and the sensitivity-adjusted summary should be reflected in intervals or other uncertainty measures.
Several approaches answer related but different questions. A complete-case mean describes those observed and does not, by itself, recover the original-cohort mean. A MAR-based analysis estimates missing outcomes using observed information but depends on the MAR assumption. Sensitivity analysis varies that assumption to assess robustness. Bounds can instead report a range of possible summaries under explicit outcome limits, sometimes at the cost of being wide. These are alternatives or complements, not interchangeable guarantees. A sensitivity analysis is useful precisely because it communicates what the data do not determine.
Common Pitfall
Correction: The value 8.0 is the mean among people observed at follow-up. The cohort mean also depends on the unobserved group. With missing fraction \(q\), observed mean \(m_{\mathrm{obs}}\), and assumed missing-group mean \(m_{\mathrm{mis}}\), it is \((1-q)m_{\mathrm{obs}}+qm_{\mathrm{mis}}\). Unless \(q=0\), or the missing-group mean is known to equal the observed mean under a justified assumption, the observed mean alone does not determine the cohort mean.
A related error is to describe a sensitivity scenario as though it were a finding about what actually happened after dropout. The accurate interpretation is conditional: if the missing-group mean were a specified amount below the benchmark, then the cohort mean would take the calculated value. That conditional statement is useful, but it is not evidence that the assumed post-dropout values occurred.
Check Your Understanding
Answer each question, then compare your reasoning with the solutions below.
- At a follow-up time, 25% of a hypothetical cohort is missing. If the missing-group mean is assumed to be 3 units below its MAR benchmark, how far does the adjusted cohort mean move from the MAR result?
- A cohort has 50% observed with mean 6.0 units and 50% missing with MAR benchmark mean 5.0 units. Under \(\delta=-1.0\), calculate the adjusted cohort mean.
- In your own words, what does a tipping point tell you, and what does it not tell you?
- Why might a biomarker after a terminal event need different treatment from a biomarker unobserved because of nonterminal dropout?
Solutions. 1. The change is \(q\delta=0.25(-3)=-0.75\) units, so the adjusted mean is 0.75 units lower than the MAR result. 2. The assumed missing mean is \(5.0-1.0=4.0\) units; the adjusted mean is \(0.50(6.0)+0.50(4.0)=3.0+2.0=5.0\) units. 3. A tipping point is the assumption value at which a specified conclusion changes. It describes sensitivity to that assumption; it does not identify the true missing outcomes or prove that the tipping-point scenario occurred. 4. After terminal events, the later biomarker may be undefined rather than merely unobserved. Imputing it as a missing value would then target a different, potentially incoherent quantity.